According to the latest report by IMARC Group, The global human insulin market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026.
Insulin is a hormone produced by the pancreas that helps in blood sugar metabolism in the body. Human insulin refers to a synthetic version of the hormone, which is produced by growing the insulin proteins within E-coli bacteria (Escherichia coli). It is prescribed to people who have diabetes to regulate fat and carbohydrate metabolism in the body. It is either taken orally or through devices, such as syringes, injection pens and pumps.
The rising prevalence of diabetes and obesity around the world represents one of the key factors driving the global human insulin market growth. In addition to this, the growing geriatric population, sedentary lifestyles and unhealthy dietary patterns are leading to an increase in incidences of metabolic disorders, which in turn, is catalyzing the demand for human insulin across the globe. Moreover, technological advancements in insulin delivery devices, such as implantable pumps, inhalers and jet injectors, are expected to propel the market growth in the coming years.
Request for a sample copy of this report: https://www.imarcgroup.com/human-insulin-market/requestsample
Insights on Market Segmentation:
Breakup by Product:
- Delivery Devices
Breakup by Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Retail Stores
View Report TOC, Figures and Tables: https://www.imarcgroup.com/human-insulin-market
Breakup by Disease Type:
- Type I Diabetes
- Type II Diabetes
Breakup by Region:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
The competitive landscape of the industry has also been examined with some of the key players being B. Braun Melsungen AG, Becton Dickinson & Company, Biocon, Eli Lilly and Company, Julphar, Novo Nordisk, Pfizer, Sanofi, Sedico, Wockhardt, Ypsomed Holding, etc.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St
Sheridan, WY 82801
Follow us on twitter: @imarcglobal